KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) EPS (Weighted Average and Diluted) (2016 - 2025)

Opko Health's EPS (Weighted Average and Diluted) history spans 15 years, with the latest figure at -$0.04 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 500.0% year-over-year to -$0.04; the TTM value through Dec 2025 reached -$0.3, down 233.33%, while the annual FY2025 figure was -$0.3, 275.0% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.04 in Q4 2025 per OPK's latest filing, down from $0.03 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.05 in Q1 2021 to a low of -$0.19 in Q2 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.06, with a median of -$0.08 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 155.56% in 2021, then tumbled 1800.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.11 in 2021, then changed by 0.0% to -$0.11 in 2022, then rose by 18.18% to -$0.09 in 2023, then soared by 111.11% to $0.01 in 2024, then crashed by 500.0% to -$0.04 in 2025.
  • Per Business Quant, the three most recent readings for OPK's EPS (Weighted Average and Diluted) are -$0.04 (Q4 2025), $0.03 (Q3 2025), and -$0.19 (Q2 2025).